Human medicines European public assessment report (EPAR): Kerendia, finerenone, Date of authorisation: 16/02/2022, Revision: 4, Status: Authorised

7 May 2026

Human medicines European public assessment report (EPAR): Dovprela (previously Pretomanid FGK), pretomanid, Date of authorisation: 31/07/2020, Revision: 14, Status: Authorised

7 May 2026

Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Date of authorisation: 14/01/2016, Revision: 20, Status: Authorised

7 May 2026

List of industry subject matter experts and list of planned calls for industry subject matter experts

7 May 2026

Record of data processing activity for Modelling and Simulation Pilot - Use of clinical study data for scientific advice

7 May 2026

European Medicines Agency's data protection notice for Modelling and Simulation Pilot - Use of clinical study data for scientific advice

7 May 2026

Clinical Trials Information System (CTIS): Information day, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 June 2026, 12:30 (CEST) to 17 June 2026, 17:30 (CEST)

7 May 2026

Human medicines European public assessment report (EPAR): Usgena, ustekinumab, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised

7 May 2026

Human medicines European public assessment report (EPAR): Olumiant, baricitinib, Date of authorisation: 13/02/2017, Revision: 25, Status: Authorised

7 May 2026

Clinical trials in human medicines

6 May 2026